Since co-injection of the NEP inhibitor PA had a significant effect on metabolic stability and consequently the tumor uptake of [111In]In-DOTA-MG11, several research groups have focused on site-specific stabilization of MG11 to circumvent its fast degradation by proteases. The gene discussed is MME; the disease is neoplasm.